Symbols / ADGM
ADGM Chart
About
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 21.39M |
| Enterprise Value | 38.37M | Income | -79.15M | Sales | 137.00K |
| Book/sh | -0.09 | Cash/sh | 0.22 | Dividend Yield | — |
| Payout | 0.00% | Employees | 80 | IPO | — |
| P/E | — | Forward P/E | -1.02 | PEG | — |
| P/S | 156.14 | P/B | -11.88 | P/C | — |
| EV/EBITDA | -1.50 | EV/Sales | 280.09 | Quick Ratio | 0.48 |
| Current Ratio | 0.84 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -2.27 | EPS next Y | -0.99 | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | -24.12% |
| ROE | -210.36% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -195.44% | Profit Margin | 0.00% | Shs Outstand | 21.18M |
| Shs Float | 3.78M | Short Float | 0.51% | Short Ratio | 0.54 |
| Short Interest | — | 52W High | 2.87 | 52W Low | 0.62 |
| Beta | 0.13 | Avg Volume | 160.25K | Volume | 15.75K |
| Target Price | $4.00 | Recom | None | Prev Close | $1.00 |
| Price | $1.01 | Change | 1.49% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$4.00
Mean price target
2. Current target
$1.00
Latest analyst target
3. DCF / Fair value
$-11.27
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.00
Low
$4.00
High
$4.00
Mean
$4.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-02 | init | Lake Street | — → Buy | $4 |
- Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study - Yahoo Finance ue, 24 Feb 2026 18
- Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study - Insider Monkey ue, 24 Feb 2026 18
- Adagio Medical Holdings Inc. Stock (ADGM) Opinions on Insider Purchase - Quiver Quantitative ue, 16 Dec 2025 08
- Usen Todd, CEO of Adagio Medical, buys $225k in Adagio stock - Investing.com Mon, 15 Dec 2025 08
- ADGM Licence and global clearing partner secured - 17:26:06 29 Jan 2026 - CABP News article - London Stock Exchange hu, 29 Jan 2026 23
- Will ADGM stock reach all time highs in 2025 - July 2025 Macro Moves & Verified Swing Trading Watchlist - mfd.ru Fri, 20 Feb 2026 21
- Pleasing Signs As A Number Of Insiders Buy Adagio Medical Holdings Stock - simplywall.st Sat, 24 Jan 2026 08
- Insider Purchase: Chief Executive Officer of $ADGM Buys 207,315 Shares | ADGM Stock News - Quiver Quantitative ue, 16 Dec 2025 08
- Circle secures ADGM license (CRCL:NYSE) - Seeking Alpha ue, 09 Dec 2025 08
- ADGM - Adagio Medical Latest Stock News & Market Updates - Stock Titan Mon, 19 Aug 2024 20
- Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Benzinga ue, 16 Dec 2025 08
- Circle (CRCL) Stock Wavers as USDC Issuer Secures ADGM License in the UAE - CoinGape ue, 09 Dec 2025 08
- Adagio Medical Holdings Inc (ADGM) reports earnings - qz.com hu, 27 Mar 2025 07
- Should I trade or invest in ADGM - 2025 Momentum Check & Free High Return Stock Watch Alerts - mfd.ru Fri, 20 Feb 2026 11
- Abu Dhabi’s ADGM reports more than 11,000 active licences, strong growth in H1 - Gulf Business ue, 09 Sep 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 15000 | 17973 | — | Purchase at price 1.20 per share. | KASTER DEBORAH | Chief Financial Officer | — | 2025-12-16 00:00:00 | D |
| 1 | 207315 | 225973 | — | Purchase at price 1.09 per share. | USEN TODD | Chief Executive Officer | — | 2025-12-12 00:00:00 | D |
| 2 | 64167 | — | — | Stock Award(Grant) at price 0.00 per share. | PERCEPTIVE ADVISORS, L.L.C. | Unknown | — | 2025-01-22 00:00:00 | D |
Financials
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -35.91M | -23.04M | -20.35M |
| TotalUnusualItems | -42.00K | 0.00 | 744.00K |
| TotalUnusualItemsExcludingGoodwill | -42.00K | 0.00 | 744.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -38.15M | -23.67M | -19.94M |
| ReconciledDepreciation | 532.00K | 495.00K | 336.00K |
| ReconciledCostOfRevenue | 1.31M | 875.00K | 1.16M |
| EBITDA | -35.95M | -23.04M | -19.60M |
| EBIT | -36.49M | -23.54M | -19.94M |
| NetInterestIncome | -1.66M | -98.00K | 3.00K |
| InterestExpense | 1.66M | 137.00K | 0.00 |
| InterestIncome | 3.00K | 39.00K | 3.00K |
| NormalizedIncome | -38.10M | -23.67M | -20.68M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -38.15M | -23.67M | -19.94M |
| TotalExpenses | 28.24M | 24.10M | 20.91M |
| TotalOperatingIncomeAsReported | -27.94M | -23.91M | -20.64M |
| DilutedAverageShares | 13.39M | 13.39M | 13.39M |
| BasicAverageShares | 13.39M | 13.39M | 13.39M |
| DilutedEPS | -2.85 | -1.77 | -1.49 |
| BasicEPS | -2.85 | -1.77 | -1.49 |
| DilutedNIAvailtoComStockholders | -38.15M | -23.67M | -19.94M |
| NetIncomeCommonStockholders | -38.15M | -23.67M | -19.94M |
| NetIncome | -38.15M | -23.67M | -19.94M |
| NetIncomeIncludingNoncontrollingInterests | -38.15M | -23.67M | -19.94M |
| NetIncomeContinuousOperations | -38.15M | -23.67M | -19.94M |
| PretaxIncome | -38.15M | -23.67M | -19.94M |
| OtherIncomeExpense | -8.55M | 338.00K | 704.00K |
| OtherNonOperatingIncomeExpenses | -8.51M | 338.00K | -40.00K |
| SpecialIncomeCharges | -8.49M | 0.00 | 744.00K |
| OtherSpecialCharges | 8.49M | -744.00K | |
| GainOnSaleOfSecurity | -42.00K | ||
| NetNonOperatingInterestIncomeExpense | -1.66M | -98.00K | 3.00K |
| InterestExpenseNonOperating | 1.66M | 137.00K | 0.00 |
| InterestIncomeNonOperating | 3.00K | 39.00K | 3.00K |
| OperatingIncome | -27.94M | -23.91M | -20.64M |
| OperatingExpense | 26.94M | 23.23M | 19.76M |
| ResearchAndDevelopment | 15.40M | 17.86M | 15.36M |
| SellingGeneralAndAdministration | 11.54M | 5.37M | 4.40M |
| GrossProfit | -1.01M | -686.00K | -888.00K |
| CostOfRevenue | 1.31M | 875.00K | 1.16M |
| TotalRevenue | 300.00K | 189.00K | 270.00K |
| OperatingRevenue | 300.00K | 189.00K | 270.00K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 15.20M | 14.54M | 13.39M | 13.39M |
| ShareIssued | 15.20M | 14.54M | 13.39M | 13.39M |
| NetDebt | 36.88M | 3.95M | ||
| TotalDebt | 16.27M | 38.40M | 9.80M | 0.00 |
| TangibleBookValue | -1.02M | -132.02M | -95.88M | -72.62M |
| InvestedCapital | 35.99M | -93.75M | -86.38M | -72.62M |
| WorkingCapital | 17.59M | -41.99M | -6.24M | 17.14M |
| NetTangibleAssets | -1.02M | -132.02M | -95.88M | -72.62M |
| CapitalLeaseObligations | 189.00K | 131.00K | 297.00K | 0.00 |
| CommonStockEquity | 19.91M | -132.02M | -95.88M | -72.62M |
| TotalCapitalization | 35.99M | -131.88M | -95.88M | -72.62M |
| TotalEquityGrossMinorityInterest | 19.91M | -132.02M | -95.88M | -72.62M |
| StockholdersEquity | 19.91M | -132.02M | -95.88M | -72.62M |
| GainsLossesNotAffectingRetainedEarnings | 1.00K | 17.00K | 28.00K | 4.00K |
| OtherEquityAdjustments | 1.00K | 17.00K | 28.00K | 4.00K |
| RetainedEarnings | -70.59M | -133.65M | -97.06M | -73.39M |
| AdditionalPaidInCapital | 90.50M | 1.61M | 1.15M | 763.00K |
| CapitalStock | 2.00K | 1.00K | 1.00K | 1.00K |
| CommonStock | 2.00K | 1.00K | 1.00K | 1.00K |
| TotalLiabilitiesNetMinorityInterest | 28.54M | 138.85M | 104.57M | 94.06M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 20.77M | 91.67M | 91.61M | 91.47M |
| OtherNonCurrentLiabilities | 3.62M | 8.00K | 3.00K | 5.00K |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 91.47M | 91.47M | 91.47M |
| DerivativeProductLiabilities | 152.00K | 0.00 | ||
| NonCurrentDeferredLiabilities | 883.00K | 0.00 | ||
| NonCurrentDeferredTaxesLiabilities | 883.00K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 16.12M | 195.00K | 134.00K | 0.00 |
| LongTermCapitalLeaseObligation | 46.00K | 52.00K | 134.00K | 0.00 |
| LongTermDebt | 16.08M | 143.00K | ||
| CurrentLiabilities | 7.76M | 47.18M | 12.97M | 2.59M |
| OtherCurrentLiabilities | 78.00K | |||
| CurrentDebtAndCapitalLeaseObligation | 143.00K | 38.20M | 9.66M | |
| CurrentCapitalLeaseObligation | 143.00K | 79.00K | 163.00K | 0.00 |
| CurrentDebt | 38.12M | 9.50M | ||
| OtherCurrentBorrowings | 38.12M | 9.50M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.62M | 1.57M | 1.23M | 843.00K |
| PayablesAndAccruedExpenses | 5.00M | 7.33M | 2.08M | 1.75M |
| CurrentAccruedExpenses | 2.16M | 3.50M | 1.06M | 1.17M |
| Payables | 2.84M | 3.83M | 1.01M | 578.00K |
| AccountsPayable | 2.84M | 3.83M | 1.01M | 578.00K |
| TotalAssets | 48.45M | 6.83M | 8.70M | 21.44M |
| TotalNonCurrentAssets | 23.10M | 1.64M | 1.97M | 1.72M |
| OtherNonCurrentAssets | 14.00K | 23.00K | 26.00K | 22.00K |
| GoodwillAndOtherIntangibleAssets | 20.94M | 0.00 | ||
| OtherIntangibleAssets | 6.97M | |||
| Goodwill | 13.97M | 0.00 | ||
| NetPPE | 2.15M | 1.62M | 1.94M | 1.70M |
| AccumulatedDepreciation | -2.73M | -1.78M | -1.24M | -772.00K |
| GrossPPE | 4.88M | 3.39M | 3.18M | 2.47M |
| Leases | 306.00K | 305.00K | 303.00K | 303.00K |
| ConstructionInProgress | 0.00 | 54.00K | 54.00K | 28.00K |
| OtherProperties | 3.57M | 1.98M | 1.84M | 255.00K |
| MachineryFurnitureEquipment | 1.00M | 1.05M | 977.00K | 1.88M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 25.35M | 5.18M | 6.73M | 19.72M |
| OtherCurrentAssets | 222.00K | 177.00K | 527.00K | 241.00K |
| PrepaidAssets | 1.94M | 232.00K | 291.00K | 263.00K |
| Inventory | 2.57M | 3.32M | 367.00K | 334.00K |
| FinishedGoods | 495.00K | 914.00K | 367.00K | 334.00K |
| WorkInProcess | 388.00K | 197.00K | 0.00 | |
| RawMaterials | 1.68M | 2.21M | 0.00 | |
| Receivables | 35.00K | 71.00K | 0.00 | 33.00K |
| AccountsReceivable | 35.00K | 71.00K | 0.00 | 33.00K |
| CashCashEquivalentsAndShortTermInvestments | 20.59M | 1.38M | 5.55M | 18.85M |
| CashAndCashEquivalents | 20.59M | 1.38M | 5.55M | 18.85M |
| Line Item | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| FreeCashFlow | -25.99M | -22.91M | -20.58M |
| RepaymentOfDebt | -1.14M | 0.00 | |
| IssuanceOfDebt | 23.00M | 9.50M | 0.00 |
| CapitalExpenditure | -340.00K | -502.00K | -1.27M |
| InterestPaidSupplementalData | 208.00K | 0.00 | |
| EndCashPosition | 1.38M | 5.55M | 18.85M |
| BeginningCashPosition | 5.55M | 18.85M | 39.23M |
| EffectOfExchangeRateChanges | -47.00K | 81.00K | 69.00K |
| ChangesInCash | -4.12M | -13.39M | -20.45M |
| FinancingCashFlow | 21.88M | 9.53M | 130.00K |
| CashFlowFromContinuingFinancingActivities | 21.88M | 9.53M | 130.00K |
| ProceedsFromStockOptionExercised | 18.00K | 25.00K | 130.00K |
| NetIssuancePaymentsOfDebt | 21.86M | 9.50M | 0.00 |
| NetShortTermDebtIssuance | 20.00M | 9.50M | 0.00 |
| ShortTermDebtIssuance | 20.00M | 9.50M | 0.00 |
| NetLongTermDebtIssuance | 21.86M | 9.50M | 0.00 |
| LongTermDebtPayments | -1.14M | 0.00 | |
| LongTermDebtIssuance | 23.00M | 9.50M | 0.00 |
| InvestingCashFlow | -340.00K | -500.00K | -1.27M |
| CashFlowFromContinuingInvestingActivities | -340.00K | -500.00K | -1.27M |
| NetIntangiblesPurchaseAndSale | -7.00K | -10.00K | -14.00K |
| PurchaseOfIntangibles | -7.00K | -10.00K | -14.00K |
| NetPPEPurchaseAndSale | -333.00K | -490.00K | -1.26M |
| SaleOfPPE | 0.00 | 2.00K | 0.00 |
| PurchaseOfPPE | -333.00K | -492.00K | -1.26M |
| OperatingCashFlow | -25.65M | -22.41M | -19.31M |
| CashFlowFromContinuingOperatingActivities | -25.65M | -22.41M | -19.31M |
| ChangeInWorkingCapital | 2.79M | 330.00K | 579.00K |
| ChangeInOtherCurrentLiabilities | -161.00K | -148.00K | -15.00K |
| ChangeInPayablesAndAccruedExpense | 5.59M | 730.00K | 1.07M |
| ChangeInAccruedExpense | 2.77M | 294.00K | 792.00K |
| ChangeInPayable | 2.82M | 436.00K | 279.00K |
| ChangeInAccountPayable | 2.82M | 436.00K | 279.00K |
| ChangeInPrepaidAssets | 410.00K | -320.00K | -44.00K |
| ChangeInInventory | -2.98M | 35.00K | -473.00K |
| ChangeInReceivables | -70.00K | 33.00K | 40.00K |
| ChangesInAccountReceivables | -70.00K | 33.00K | 40.00K |
| OtherNonCashItems | 8.66M | 147.00K | |
| StockBasedCompensation | 442.00K | 365.00K | 339.00K |
| AssetImpairmentCharge | 25.00K | -76.00K | 121.00K |
| DepreciationAmortizationDepletion | 532.00K | 495.00K | 336.00K |
| DepreciationAndAmortization | 532.00K | 495.00K | 336.00K |
| OperatingGainsLosses | 45.00K | -744.00K | |
| GainLossOnInvestmentSecurities | 42.00K | ||
| GainLossOnSaleOfPPE | 3.00K | 0.00 | |
| NetIncomeFromContinuingOperations | -38.15M | -23.67M | -19.94M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ADGM
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|